GlaxoSmithKline - McKnight's Long Term Care News

GlaxoSmithKline

FDA approves Anoro Ellipta

The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.

Flu vaccines approved to ship

GlaxoSmithKline said it has received Food and Drug Administration approval to start shipping the 2013-2014 influenza virus vaccine to Centers for Disease Control and Prevention distribution centers and healthcare providers.

Next post in News